The global Histone Deacetylase 1 market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
In terms of production side, this report researches the Histone Deacetylase 1 production capacity, value, ex-factory price, growth rate, market share by manufacturers, regions (or countries) and by Type.
In terms of consumption side, this report focuses on the consumption of Histone Deacetylase 1 by regions (countries) and by Application.
The global Histone Deacetylase 1 market is thoroughly, accurately, and comprehensively assessed in the report with a large focus on market dynamics, market competition, regional growth, segmental analysis, and key growth strategies. Buyers of the report will have access to verified market figures, including global market size in terms of revenue and volume. As part of production analysis, the authors of the report have provided reliable estimations and calculations for global revenue and volume by Type segment of the global Histone Deacetylase 1 market. These figures have been provided in terms of both revenue and volume for the period 2016-2027. Additionally, the report provides accurate figures for production by region in terms of revenue as well as volume for the same period. The report also includes production capacity statistics for the same period.
Geographic Segmentation
The report offers exhaustive assessment of different region-wise Histone Deacetylase 1 markets such as North America, Europe, China and Japan, etc. Key regions covered in the report are U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, UAE
For the period 2016-2027, the report provides country-wise revenue and volume sales analysis and region-wise revenue and volume analysis of the global Histone Deacetylase 1 market. For the period 2016-2021, it provides sales (consumption) analysis and forecast of different regional markets by each application as well as type segment in terms of volume.
Manufacturers
The report includes comprehensive company profiling of leading and emerging companies competing in the global Histone Deacetylase 1 market. It provides a detailed list of players operating at a global level. The players have been listed according to the type of products they offer in the global Histone Deacetylase 1 market and other factors. As part of the company profiling, the analysts authoring the report has provided the market entry year of each player considered for the research study. The report also offers extensive price, volume sales, and revenue analysis by the manufacturer at the global level for the period 2016-2021.
By Type and Application Segments
The report includes a detailed analysis of leading and type and application segments of the global Histone Deacetylase 1 market. All of the segments covered in the report are broadly analyzed based on some deciding factors. The segmental analysis section of the report offers revenue sales analysis and forecast of the global Histone Deacetylase 1 market by each type segment for the period 2016-2027. It also offers volume sales (consumption) analysis and forecast of the global Histone Deacetylase 1 market by each type segment for the same period. Also, it provides volume sales (consumption) analysis and forecast of the global Histone Deacetylase 1 market by each application segment for the same period.
This report includes the following manufacturers:
4SC AG
Acetylon Pharmaceuticals, Inc.
Chipscreen Biosciences Ltd
Curis, Inc.
GlaxoSmithKline Plc
HitGen LTD
IRBM Science Park SpA
Italfarmaco S.p.A.
MEI Pharma, Inc.
Merck & Co., Inc.
Mirati Therapeutics Inc.
Oncolys BioPharma Inc.
Sigma-Tau S.p.A.
Syndax Pharmaceuticals, Inc.
TetraLogic Pharmaceuticals
Market Segment by Type
RCY-1305
HG-3001
CS-3158
ACY-957
ST-3595
Others
Market Segment by Application
Alopecia
Endometrial Cancer
Myelofibrosis
Neurology
Skin Cancer
Others
Research Methodology
To compile the detailed study of the global Histone Deacetylase 1 market, a robust research methodology has been adopted that aids in determining the key insights and also evaluates the growth prospects of the Histone Deacetylase 1 market. LBI Research analysts have conducted in-depth primary and secondary research to obtain crucial insights into the Histone Deacetylase 1 market. To carry out secondary research, the analysts have collected the information through company annual reports, journals, company press releases, and paid databases that were referred to gain and identify better opportunities in the global market.
In terms of production side, this report researches the Histone Deacetylase 1 production capacity, value, ex-factory price, growth rate, market share by manufacturers, regions (or countries) and by Type.
In terms of consumption side, this report focuses on the consumption of Histone Deacetylase 1 by regions (countries) and by Application.
The global Histone Deacetylase 1 market is thoroughly, accurately, and comprehensively assessed in the report with a large focus on market dynamics, market competition, regional growth, segmental analysis, and key growth strategies. Buyers of the report will have access to verified market figures, including global market size in terms of revenue and volume. As part of production analysis, the authors of the report have provided reliable estimations and calculations for global revenue and volume by Type segment of the global Histone Deacetylase 1 market. These figures have been provided in terms of both revenue and volume for the period 2016-2027. Additionally, the report provides accurate figures for production by region in terms of revenue as well as volume for the same period. The report also includes production capacity statistics for the same period.
Geographic Segmentation
The report offers exhaustive assessment of different region-wise Histone Deacetylase 1 markets such as North America, Europe, China and Japan, etc. Key regions covered in the report are U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, UAE
For the period 2016-2027, the report provides country-wise revenue and volume sales analysis and region-wise revenue and volume analysis of the global Histone Deacetylase 1 market. For the period 2016-2021, it provides sales (consumption) analysis and forecast of different regional markets by each application as well as type segment in terms of volume.
Manufacturers
The report includes comprehensive company profiling of leading and emerging companies competing in the global Histone Deacetylase 1 market. It provides a detailed list of players operating at a global level. The players have been listed according to the type of products they offer in the global Histone Deacetylase 1 market and other factors. As part of the company profiling, the analysts authoring the report has provided the market entry year of each player considered for the research study. The report also offers extensive price, volume sales, and revenue analysis by the manufacturer at the global level for the period 2016-2021.
By Type and Application Segments
The report includes a detailed analysis of leading and type and application segments of the global Histone Deacetylase 1 market. All of the segments covered in the report are broadly analyzed based on some deciding factors. The segmental analysis section of the report offers revenue sales analysis and forecast of the global Histone Deacetylase 1 market by each type segment for the period 2016-2027. It also offers volume sales (consumption) analysis and forecast of the global Histone Deacetylase 1 market by each type segment for the same period. Also, it provides volume sales (consumption) analysis and forecast of the global Histone Deacetylase 1 market by each application segment for the same period.
This report includes the following manufacturers:
4SC AG
Acetylon Pharmaceuticals, Inc.
Chipscreen Biosciences Ltd
Curis, Inc.
GlaxoSmithKline Plc
HitGen LTD
IRBM Science Park SpA
Italfarmaco S.p.A.
MEI Pharma, Inc.
Merck & Co., Inc.
Mirati Therapeutics Inc.
Oncolys BioPharma Inc.
Sigma-Tau S.p.A.
Syndax Pharmaceuticals, Inc.
TetraLogic Pharmaceuticals
Market Segment by Type
RCY-1305
HG-3001
CS-3158
ACY-957
ST-3595
Others
Market Segment by Application
Alopecia
Endometrial Cancer
Myelofibrosis
Neurology
Skin Cancer
Others
Research Methodology
To compile the detailed study of the global Histone Deacetylase 1 market, a robust research methodology has been adopted that aids in determining the key insights and also evaluates the growth prospects of the Histone Deacetylase 1 market. LBI Research analysts have conducted in-depth primary and secondary research to obtain crucial insights into the Histone Deacetylase 1 market. To carry out secondary research, the analysts have collected the information through company annual reports, journals, company press releases, and paid databases that were referred to gain and identify better opportunities in the global market.
1 Report Overview
1.1 Research Scope
1.2 Market Segment by Type
1.2.1 Global Histone Deacetylase 1 Market Size Growth Rate by Type
1.2.2 RCY-1305
1.2.3 HG-3001
1.2.4 CS-3158
1.2.5 ACY-957
1.2.6 ST-3595
1.2.7 Others
1.3 Market Segment by Application
1.3.1 Global Histone Deacetylase 1 Market Share by Application (2016 VS 2021 VS 2027)
1.3.2 Alopecia
1.3.3 Endometrial Cancer
1.3.4 Myelofibrosis
1.3.5 Neurology
1.3.6 Skin Cancer
1.3.7 Others
1.4 Study Objectives
1.5 Years Considered
2 Market Perspective
2.1 Global Histone Deacetylase 1 Market Size (2016-2027)
2.1.1 Global Histone Deacetylase 1 Revenue (2016-2027)
2.1.2 Global Histone Deacetylase 1 Sales (2016-2027)
2.2 Global Histone Deacetylase 1 Market Size across Key Geographies Worldwide: 2016 VS 2021 VS 2027
2.2.1 Global Histone Deacetylase 1 Sales by Regions (2016-2021)
2.2.2 Global Histone Deacetylase 1 Revenue by Regions (2016-2021)
2.3 Global Histone Deacetylase 1 Market Size Forecast by Region
2.3.1 Global Histone Deacetylase 1 Sales Forecast by Region (2022-2027)
2.3.2 Global Histone Deacetylase 1 Revenue Forecast by Region (2022-2027)
2.4 Global Top Histone Deacetylase 1 Regions (Countries) Ranking by Market Size
2.5 Histone Deacetylase 1 Industry Trends
2.5.1 Histone Deacetylase 1 Market Trends
2.5.2 Histone Deacetylase 1 Market Drivers
2.5.3 Histone Deacetylase 1 Market Challenges
2.5.4 Histone Deacetylase 1 Market Restraints
3 Competitive Landscape by Manufacturers
3.1 Global Top Histone Deacetylase 1 Manufacturers by Sales (2016-2021)
3.1.1 Global Histone Deacetylase 1 Sales by Manufacturers (2016-2021)
3.1.2 Global Histone Deacetylase 1 Sales Market Share by Manufacturers (2016-2021)
3.1.3 Global 5 and 10 Largest Manufacturers by Histone Deacetylase 1 Sales in 2020
3.2 Global Top Manufacturers Histone Deacetylase 1 by Revenue
3.2.1 Global Histone Deacetylase 1 Revenue by Manufacturers (2016-2021)
3.2.2 Top Histone Deacetylase 1 Manufacturers Covered: Ranking by Revenue
3.2.3 Global Histone Deacetylase 1 Revenue Share by Manufacturers (2016-2021)
3.2.4 Global Histone Deacetylase 1 Market Concentration Ratio (CR5 and HHI)
3.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Histone Deacetylase 1 as of 2020)
3.4 Global Histone Deacetylase 1 Average Selling Price (ASP) by Manufacturers
3.5 Key Manufacturers Histone Deacetylase 1 Plants/Factories Distribution and Area Served
3.6 Date of Key Manufacturers Enter into Histone Deacetylase 1 Market
3.7 Key Manufacturers Histone Deacetylase 1 Product Offered
3.8 Mergers & Acquisitions, Expansion Plans
4 Global Histone Deacetylase 1 Market Size by Type
4.1 Global Histone Deacetylase 1 Historic Market Review by Type (2016-2021)
4.1.1 Global Histone Deacetylase 1 Sales Market Share by Type (2016-2021)
4.1.2 Global Histone Deacetylase 1 Revenue Market Share by Type (2016-2021)
4.1.3 Histone Deacetylase 1 Price by Type (2016-2021)
4.2 Global Histone Deacetylase 1 Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Histone Deacetylase 1 Sales Forecast by Type (2022-2027)
4.2.2 Global Histone Deacetylase 1 Revenue Forecast by Type (2022-2027)
4.2.3 Histone Deacetylase 1 Price Forecast by Type (2022-2027)
5 Global Histone Deacetylase 1 Market Size by Application
5.1 Global Histone Deacetylase 1 Historic Market Review by Application (2016-2021)
5.1.1 Global Histone Deacetylase 1 Sales Market Share by Application (2016-2021)
5.1.2 Global Histone Deacetylase 1 Revenue Market Share by Application (2016-2021)
5.1.3 Histone Deacetylase 1 Price by Application (2016-2021)
5.2 Global Histone Deacetylase 1 Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Histone Deacetylase 1 Sales Forecast by Application (2022-2027)
5.2.2 Global Histone Deacetylase 1 Revenue Forecast by Application (2022-2027)
5.2.3 Histone Deacetylase 1 Price Forecast by Application (2022-2027)
6 North America
6.1 North America Histone Deacetylase 1 Sales Breakdown by Company
6.1.1 North America Histone Deacetylase 1 Sales by Company (2016-2027)
6.1.2 North America Histone Deacetylase 1 Revenue by Company (2016-2027)
6.2 North America Histone Deacetylase 1 Market Size by Type (2016-2027)
6.2.1 North America Histone Deacetylase 1 Sales by Type (2016-2027)
6.2.2 North America Histone Deacetylase 1 Revenue by Type (2016-2027)
6.3 North America Histone Deacetylase 1 Market Size by Application (2016-2027)
6.3.1 North America Histone Deacetylase 1 Sales by Application (2016-2027)
6.3.2 North America Histone Deacetylase 1 Revenue by Application (2016-2027)
6.4 North America Histone Deacetylase 1 Market Size by Country
6.4.1 North America Histone Deacetylase 1 Sales by Country (2016-2027)
6.4.2 North America Histone Deacetylase 1 Revenue by Country (2016-2027)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Histone Deacetylase 1 Sales Breakdown by Company
7.1.1 Europe Histone Deacetylase 1 Sales by Company (2016-2027)
7.1.2 Europe Histone Deacetylase 1 Revenue by Company (2016-2027)
7.2 Europe Histone Deacetylase 1 Market Size by Type (2016-2027)
7.2.1 Europe Histone Deacetylase 1 Sales by Type (2016-2027)
7.2.2 Europe Histone Deacetylase 1 Revenue by Type (2016-2027)
7.3 Europe Histone Deacetylase 1 Market Size by Application (2016-2027)
7.3.1 Europe Histone Deacetylase 1 Sales by Application (2016-2027)
7.3.2 Europe Histone Deacetylase 1 Revenue by Application (2016-2027)
7.4 Europe Histone Deacetylase 1 Market Size by Country
7.4.1 Europe Histone Deacetylase 1 Sales by Country (2016-2027)
7.4.2 Europe Histone Deacetylase 1 Revenue by Country (2016-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
8 Asia Pacific
8.1 Asia Pacific Histone Deacetylase 1 Sales Breakdown by Company
8.1.1 Asia Pacific Histone Deacetylase 1 Sales by Company (2016-2027)
8.1.2 Asia Pacific Histone Deacetylase 1 Revenue by Company (2016-2027)
8.2 Asia Pacific Histone Deacetylase 1 Market Size by Type (2016-2027)
8.2.1 Asia Pacific Histone Deacetylase 1 Sales by Type (2016-2027)
8.2.2 Asia Pacific Histone Deacetylase 1 Revenue by Type (2016-2027)
8.3 Asia Pacific Histone Deacetylase 1 Market Size by Application (2016-2027)
8.3.1 Asia Pacific Histone Deacetylase 1 Sales by Application (2016-2027)
8.3.2 Asia Pacific Histone Deacetylase 1 Revenue by Application (2016-2027)
8.4 Asia Pacific Histone Deacetylase 1 Market Size by Regions
8.4.1 Asia Pacific Histone Deacetylase 1 Sales by Regions
8.4.2 Asia Pacific Histone Deacetylase 1 Revenue by Regions
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 India
8.4.7 Australia
8.4.8 Taiwan
8.4.9 Indonesia
8.4.10 Thailand
8.4.11 Malaysia
8.4.12 Philippines
8.4.13 Vietnam
9 Latin America
9.1 Latin America Histone Deacetylase 1 Sales Breakdown by Company
9.1.1 Latin America Histone Deacetylase 1 Sales by Company (2016-2027)
9.1.2 Latin America Histone Deacetylase 1 Revenue by Company (2016-2027)
9.2 Latin America Histone Deacetylase 1 Market Size by Type (2016-2027)
9.2.1 Latin America Histone Deacetylase 1 Sales by Type (2016-2027)
9.2.2 Latin America Histone Deacetylase 1 Revenue by Type (2016-2027)
9.3 Latin America Histone Deacetylase 1 Market Size by Application (2016-2027)
9.3.1 Latin America Histone Deacetylase 1 Sales by Application (2016-2027)
9.3.2 Latin America Histone Deacetylase 1 Revenue by Application (2016-2027)
9.4 Latin America Histone Deacetylase 1 Market Size by Country
9.4.1 Latin America Histone Deacetylase 1 Sales by Country (2016-2027)
9.4.2 Latin America Histone Deacetylase 1 Revenue by Country (2016-2027)
9.4.3 Mexico
9.4.4 Brazil
9.4.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Histone Deacetylase 1 Sales Breakdown by Company
10.1.1 Middle East and Africa Histone Deacetylase 1 Sales by Company (2016-2027)
10.1.2 Middle East and Africa Histone Deacetylase 1 Revenue by Company (2016-2027)
10.2 Middle East and Africa Histone Deacetylase 1 Market Size by Type (2016-2027)
10.2.1 Middle East and Africa Histone Deacetylase 1 Sales by Type (2016-2027)
10.2.2 Middle East and Africa Histone Deacetylase 1 Revenue by Type (2016-2027)
10.3 Middle East and Africa Histone Deacetylase 1 Market Size by Application (2016-2027)
10.3.1 Middle East and Africa Histone Deacetylase 1 Sales by Application (2016-2027)
10.3.2 Middle East and Africa Histone Deacetylase 1 Revenue by Application (2016-2027)
10.4 Middle East and Africa Histone Deacetylase 1 Market Size by Country
10.4.1 Middle East and Africa Histone Deacetylase 1 Sales by Country (2016-2027)
10.4.2 Middle East and Africa Histone Deacetylase 1 Revenue by Country (2016-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Company Profiles
11.1 4SC AG
11.1.1 4SC AG Corporation Information
11.1.2 4SC AG Overview
11.1.3 4SC AG Histone Deacetylase 1 Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.1.4 4SC AG Histone Deacetylase 1 Products and Services
11.1.5 4SC AG Histone Deacetylase 1 SWOT Analysis
11.1.6 4SC AG Recent Developments
11.2 Acetylon Pharmaceuticals, Inc.
11.2.1 Acetylon Pharmaceuticals, Inc. Corporation Information
11.2.2 Acetylon Pharmaceuticals, Inc. Overview
11.2.3 Acetylon Pharmaceuticals, Inc. Histone Deacetylase 1 Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.2.4 Acetylon Pharmaceuticals, Inc. Histone Deacetylase 1 Products and Services
11.2.5 Acetylon Pharmaceuticals, Inc. Histone Deacetylase 1 SWOT Analysis
11.2.6 Acetylon Pharmaceuticals, Inc. Recent Developments
11.3 Chipscreen Biosciences Ltd
11.3.1 Chipscreen Biosciences Ltd Corporation Information
11.3.2 Chipscreen Biosciences Ltd Overview
11.3.3 Chipscreen Biosciences Ltd Histone Deacetylase 1 Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.3.4 Chipscreen Biosciences Ltd Histone Deacetylase 1 Products and Services
11.3.5 Chipscreen Biosciences Ltd Histone Deacetylase 1 SWOT Analysis
11.3.6 Chipscreen Biosciences Ltd Recent Developments
11.4 Curis, Inc.
11.4.1 Curis, Inc. Corporation Information
11.4.2 Curis, Inc. Overview
11.4.3 Curis, Inc. Histone Deacetylase 1 Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.4.4 Curis, Inc. Histone Deacetylase 1 Products and Services
11.4.5 Curis, Inc. Histone Deacetylase 1 SWOT Analysis
11.4.6 Curis, Inc. Recent Developments
11.5 GlaxoSmithKline Plc
11.5.1 GlaxoSmithKline Plc Corporation Information
11.5.2 GlaxoSmithKline Plc Overview
11.5.3 GlaxoSmithKline Plc Histone Deacetylase 1 Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.5.4 GlaxoSmithKline Plc Histone Deacetylase 1 Products and Services
11.5.5 GlaxoSmithKline Plc Histone Deacetylase 1 SWOT Analysis
11.5.6 GlaxoSmithKline Plc Recent Developments
11.6 HitGen LTD
11.6.1 HitGen LTD Corporation Information
11.6.2 HitGen LTD Overview
11.6.3 HitGen LTD Histone Deacetylase 1 Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.6.4 HitGen LTD Histone Deacetylase 1 Products and Services
11.6.5 HitGen LTD Histone Deacetylase 1 SWOT Analysis
11.6.6 HitGen LTD Recent Developments
11.7 IRBM Science Park SpA
11.7.1 IRBM Science Park SpA Corporation Information
11.7.2 IRBM Science Park SpA Overview
11.7.3 IRBM Science Park SpA Histone Deacetylase 1 Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.7.4 IRBM Science Park SpA Histone Deacetylase 1 Products and Services
11.7.5 IRBM Science Park SpA Histone Deacetylase 1 SWOT Analysis
11.7.6 IRBM Science Park SpA Recent Developments
11.8 Italfarmaco S.p.A.
11.8.1 Italfarmaco S.p.A. Corporation Information
11.8.2 Italfarmaco S.p.A. Overview
11.8.3 Italfarmaco S.p.A. Histone Deacetylase 1 Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.8.4 Italfarmaco S.p.A. Histone Deacetylase 1 Products and Services
11.8.5 Italfarmaco S.p.A. Histone Deacetylase 1 SWOT Analysis
11.8.6 Italfarmaco S.p.A. Recent Developments
11.9 MEI Pharma, Inc.
11.9.1 MEI Pharma, Inc. Corporation Information
11.9.2 MEI Pharma, Inc. Overview
11.9.3 MEI Pharma, Inc. Histone Deacetylase 1 Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.9.4 MEI Pharma, Inc. Histone Deacetylase 1 Products and Services
11.9.5 MEI Pharma, Inc. Histone Deacetylase 1 SWOT Analysis
11.9.6 MEI Pharma, Inc. Recent Developments
11.10 Merck & Co., Inc.
11.10.1 Merck & Co., Inc. Corporation Information
11.10.2 Merck & Co., Inc. Overview
11.10.3 Merck & Co., Inc. Histone Deacetylase 1 Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.10.4 Merck & Co., Inc. Histone Deacetylase 1 Products and Services
11.10.5 Merck & Co., Inc. Histone Deacetylase 1 SWOT Analysis
11.10.6 Merck & Co., Inc. Recent Developments
11.11 Mirati Therapeutics Inc.
11.11.1 Mirati Therapeutics Inc. Corporation Information
11.11.2 Mirati Therapeutics Inc. Overview
11.11.3 Mirati Therapeutics Inc. Histone Deacetylase 1 Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.11.4 Mirati Therapeutics Inc. Histone Deacetylase 1 Products and Services
11.11.5 Mirati Therapeutics Inc. Recent Developments
11.12 Oncolys BioPharma Inc.
11.12.1 Oncolys BioPharma Inc. Corporation Information
11.12.2 Oncolys BioPharma Inc. Overview
11.12.3 Oncolys BioPharma Inc. Histone Deacetylase 1 Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.12.4 Oncolys BioPharma Inc. Histone Deacetylase 1 Products and Services
11.12.5 Oncolys BioPharma Inc. Recent Developments
11.13 Sigma-Tau S.p.A.
11.13.1 Sigma-Tau S.p.A. Corporation Information
11.13.2 Sigma-Tau S.p.A. Overview
11.13.3 Sigma-Tau S.p.A. Histone Deacetylase 1 Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.13.4 Sigma-Tau S.p.A. Histone Deacetylase 1 Products and Services
11.13.5 Sigma-Tau S.p.A. Recent Developments
11.14 Syndax Pharmaceuticals, Inc.
11.14.1 Syndax Pharmaceuticals, Inc. Corporation Information
11.14.2 Syndax Pharmaceuticals, Inc. Overview
11.14.3 Syndax Pharmaceuticals, Inc. Histone Deacetylase 1 Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.14.4 Syndax Pharmaceuticals, Inc. Histone Deacetylase 1 Products and Services
11.14.5 Syndax Pharmaceuticals, Inc. Recent Developments
11.15 TetraLogic Pharmaceuticals
11.15.1 TetraLogic Pharmaceuticals Corporation Information
11.15.2 TetraLogic Pharmaceuticals Overview
11.15.3 TetraLogic Pharmaceuticals Histone Deacetylase 1 Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.15.4 TetraLogic Pharmaceuticals Histone Deacetylase 1 Products and Services
11.15.5 TetraLogic Pharmaceuticals Recent Developments
12 Value Chain and Sales Channels Analysis
12.1 Histone Deacetylase 1 Value Chain Analysis
12.2 Histone Deacetylase 1 Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Histone Deacetylase 1 Production Mode & Process
12.4 Histone Deacetylase 1 Sales and Marketing
12.4.1 Histone Deacetylase 1 Sales Channels
12.4.2 Histone Deacetylase 1 Distributors
12.5 Histone Deacetylase 1 Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
1.1 Research Scope
1.2 Market Segment by Type
1.2.1 Global Histone Deacetylase 1 Market Size Growth Rate by Type
1.2.2 RCY-1305
1.2.3 HG-3001
1.2.4 CS-3158
1.2.5 ACY-957
1.2.6 ST-3595
1.2.7 Others
1.3 Market Segment by Application
1.3.1 Global Histone Deacetylase 1 Market Share by Application (2016 VS 2021 VS 2027)
1.3.2 Alopecia
1.3.3 Endometrial Cancer
1.3.4 Myelofibrosis
1.3.5 Neurology
1.3.6 Skin Cancer
1.3.7 Others
1.4 Study Objectives
1.5 Years Considered
2 Market Perspective
2.1 Global Histone Deacetylase 1 Market Size (2016-2027)
2.1.1 Global Histone Deacetylase 1 Revenue (2016-2027)
2.1.2 Global Histone Deacetylase 1 Sales (2016-2027)
2.2 Global Histone Deacetylase 1 Market Size across Key Geographies Worldwide: 2016 VS 2021 VS 2027
2.2.1 Global Histone Deacetylase 1 Sales by Regions (2016-2021)
2.2.2 Global Histone Deacetylase 1 Revenue by Regions (2016-2021)
2.3 Global Histone Deacetylase 1 Market Size Forecast by Region
2.3.1 Global Histone Deacetylase 1 Sales Forecast by Region (2022-2027)
2.3.2 Global Histone Deacetylase 1 Revenue Forecast by Region (2022-2027)
2.4 Global Top Histone Deacetylase 1 Regions (Countries) Ranking by Market Size
2.5 Histone Deacetylase 1 Industry Trends
2.5.1 Histone Deacetylase 1 Market Trends
2.5.2 Histone Deacetylase 1 Market Drivers
2.5.3 Histone Deacetylase 1 Market Challenges
2.5.4 Histone Deacetylase 1 Market Restraints
3 Competitive Landscape by Manufacturers
3.1 Global Top Histone Deacetylase 1 Manufacturers by Sales (2016-2021)
3.1.1 Global Histone Deacetylase 1 Sales by Manufacturers (2016-2021)
3.1.2 Global Histone Deacetylase 1 Sales Market Share by Manufacturers (2016-2021)
3.1.3 Global 5 and 10 Largest Manufacturers by Histone Deacetylase 1 Sales in 2020
3.2 Global Top Manufacturers Histone Deacetylase 1 by Revenue
3.2.1 Global Histone Deacetylase 1 Revenue by Manufacturers (2016-2021)
3.2.2 Top Histone Deacetylase 1 Manufacturers Covered: Ranking by Revenue
3.2.3 Global Histone Deacetylase 1 Revenue Share by Manufacturers (2016-2021)
3.2.4 Global Histone Deacetylase 1 Market Concentration Ratio (CR5 and HHI)
3.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Histone Deacetylase 1 as of 2020)
3.4 Global Histone Deacetylase 1 Average Selling Price (ASP) by Manufacturers
3.5 Key Manufacturers Histone Deacetylase 1 Plants/Factories Distribution and Area Served
3.6 Date of Key Manufacturers Enter into Histone Deacetylase 1 Market
3.7 Key Manufacturers Histone Deacetylase 1 Product Offered
3.8 Mergers & Acquisitions, Expansion Plans
4 Global Histone Deacetylase 1 Market Size by Type
4.1 Global Histone Deacetylase 1 Historic Market Review by Type (2016-2021)
4.1.1 Global Histone Deacetylase 1 Sales Market Share by Type (2016-2021)
4.1.2 Global Histone Deacetylase 1 Revenue Market Share by Type (2016-2021)
4.1.3 Histone Deacetylase 1 Price by Type (2016-2021)
4.2 Global Histone Deacetylase 1 Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Histone Deacetylase 1 Sales Forecast by Type (2022-2027)
4.2.2 Global Histone Deacetylase 1 Revenue Forecast by Type (2022-2027)
4.2.3 Histone Deacetylase 1 Price Forecast by Type (2022-2027)
5 Global Histone Deacetylase 1 Market Size by Application
5.1 Global Histone Deacetylase 1 Historic Market Review by Application (2016-2021)
5.1.1 Global Histone Deacetylase 1 Sales Market Share by Application (2016-2021)
5.1.2 Global Histone Deacetylase 1 Revenue Market Share by Application (2016-2021)
5.1.3 Histone Deacetylase 1 Price by Application (2016-2021)
5.2 Global Histone Deacetylase 1 Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Histone Deacetylase 1 Sales Forecast by Application (2022-2027)
5.2.2 Global Histone Deacetylase 1 Revenue Forecast by Application (2022-2027)
5.2.3 Histone Deacetylase 1 Price Forecast by Application (2022-2027)
6 North America
6.1 North America Histone Deacetylase 1 Sales Breakdown by Company
6.1.1 North America Histone Deacetylase 1 Sales by Company (2016-2027)
6.1.2 North America Histone Deacetylase 1 Revenue by Company (2016-2027)
6.2 North America Histone Deacetylase 1 Market Size by Type (2016-2027)
6.2.1 North America Histone Deacetylase 1 Sales by Type (2016-2027)
6.2.2 North America Histone Deacetylase 1 Revenue by Type (2016-2027)
6.3 North America Histone Deacetylase 1 Market Size by Application (2016-2027)
6.3.1 North America Histone Deacetylase 1 Sales by Application (2016-2027)
6.3.2 North America Histone Deacetylase 1 Revenue by Application (2016-2027)
6.4 North America Histone Deacetylase 1 Market Size by Country
6.4.1 North America Histone Deacetylase 1 Sales by Country (2016-2027)
6.4.2 North America Histone Deacetylase 1 Revenue by Country (2016-2027)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Histone Deacetylase 1 Sales Breakdown by Company
7.1.1 Europe Histone Deacetylase 1 Sales by Company (2016-2027)
7.1.2 Europe Histone Deacetylase 1 Revenue by Company (2016-2027)
7.2 Europe Histone Deacetylase 1 Market Size by Type (2016-2027)
7.2.1 Europe Histone Deacetylase 1 Sales by Type (2016-2027)
7.2.2 Europe Histone Deacetylase 1 Revenue by Type (2016-2027)
7.3 Europe Histone Deacetylase 1 Market Size by Application (2016-2027)
7.3.1 Europe Histone Deacetylase 1 Sales by Application (2016-2027)
7.3.2 Europe Histone Deacetylase 1 Revenue by Application (2016-2027)
7.4 Europe Histone Deacetylase 1 Market Size by Country
7.4.1 Europe Histone Deacetylase 1 Sales by Country (2016-2027)
7.4.2 Europe Histone Deacetylase 1 Revenue by Country (2016-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
8 Asia Pacific
8.1 Asia Pacific Histone Deacetylase 1 Sales Breakdown by Company
8.1.1 Asia Pacific Histone Deacetylase 1 Sales by Company (2016-2027)
8.1.2 Asia Pacific Histone Deacetylase 1 Revenue by Company (2016-2027)
8.2 Asia Pacific Histone Deacetylase 1 Market Size by Type (2016-2027)
8.2.1 Asia Pacific Histone Deacetylase 1 Sales by Type (2016-2027)
8.2.2 Asia Pacific Histone Deacetylase 1 Revenue by Type (2016-2027)
8.3 Asia Pacific Histone Deacetylase 1 Market Size by Application (2016-2027)
8.3.1 Asia Pacific Histone Deacetylase 1 Sales by Application (2016-2027)
8.3.2 Asia Pacific Histone Deacetylase 1 Revenue by Application (2016-2027)
8.4 Asia Pacific Histone Deacetylase 1 Market Size by Regions
8.4.1 Asia Pacific Histone Deacetylase 1 Sales by Regions
8.4.2 Asia Pacific Histone Deacetylase 1 Revenue by Regions
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 India
8.4.7 Australia
8.4.8 Taiwan
8.4.9 Indonesia
8.4.10 Thailand
8.4.11 Malaysia
8.4.12 Philippines
8.4.13 Vietnam
9 Latin America
9.1 Latin America Histone Deacetylase 1 Sales Breakdown by Company
9.1.1 Latin America Histone Deacetylase 1 Sales by Company (2016-2027)
9.1.2 Latin America Histone Deacetylase 1 Revenue by Company (2016-2027)
9.2 Latin America Histone Deacetylase 1 Market Size by Type (2016-2027)
9.2.1 Latin America Histone Deacetylase 1 Sales by Type (2016-2027)
9.2.2 Latin America Histone Deacetylase 1 Revenue by Type (2016-2027)
9.3 Latin America Histone Deacetylase 1 Market Size by Application (2016-2027)
9.3.1 Latin America Histone Deacetylase 1 Sales by Application (2016-2027)
9.3.2 Latin America Histone Deacetylase 1 Revenue by Application (2016-2027)
9.4 Latin America Histone Deacetylase 1 Market Size by Country
9.4.1 Latin America Histone Deacetylase 1 Sales by Country (2016-2027)
9.4.2 Latin America Histone Deacetylase 1 Revenue by Country (2016-2027)
9.4.3 Mexico
9.4.4 Brazil
9.4.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Histone Deacetylase 1 Sales Breakdown by Company
10.1.1 Middle East and Africa Histone Deacetylase 1 Sales by Company (2016-2027)
10.1.2 Middle East and Africa Histone Deacetylase 1 Revenue by Company (2016-2027)
10.2 Middle East and Africa Histone Deacetylase 1 Market Size by Type (2016-2027)
10.2.1 Middle East and Africa Histone Deacetylase 1 Sales by Type (2016-2027)
10.2.2 Middle East and Africa Histone Deacetylase 1 Revenue by Type (2016-2027)
10.3 Middle East and Africa Histone Deacetylase 1 Market Size by Application (2016-2027)
10.3.1 Middle East and Africa Histone Deacetylase 1 Sales by Application (2016-2027)
10.3.2 Middle East and Africa Histone Deacetylase 1 Revenue by Application (2016-2027)
10.4 Middle East and Africa Histone Deacetylase 1 Market Size by Country
10.4.1 Middle East and Africa Histone Deacetylase 1 Sales by Country (2016-2027)
10.4.2 Middle East and Africa Histone Deacetylase 1 Revenue by Country (2016-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Company Profiles
11.1 4SC AG
11.1.1 4SC AG Corporation Information
11.1.2 4SC AG Overview
11.1.3 4SC AG Histone Deacetylase 1 Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.1.4 4SC AG Histone Deacetylase 1 Products and Services
11.1.5 4SC AG Histone Deacetylase 1 SWOT Analysis
11.1.6 4SC AG Recent Developments
11.2 Acetylon Pharmaceuticals, Inc.
11.2.1 Acetylon Pharmaceuticals, Inc. Corporation Information
11.2.2 Acetylon Pharmaceuticals, Inc. Overview
11.2.3 Acetylon Pharmaceuticals, Inc. Histone Deacetylase 1 Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.2.4 Acetylon Pharmaceuticals, Inc. Histone Deacetylase 1 Products and Services
11.2.5 Acetylon Pharmaceuticals, Inc. Histone Deacetylase 1 SWOT Analysis
11.2.6 Acetylon Pharmaceuticals, Inc. Recent Developments
11.3 Chipscreen Biosciences Ltd
11.3.1 Chipscreen Biosciences Ltd Corporation Information
11.3.2 Chipscreen Biosciences Ltd Overview
11.3.3 Chipscreen Biosciences Ltd Histone Deacetylase 1 Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.3.4 Chipscreen Biosciences Ltd Histone Deacetylase 1 Products and Services
11.3.5 Chipscreen Biosciences Ltd Histone Deacetylase 1 SWOT Analysis
11.3.6 Chipscreen Biosciences Ltd Recent Developments
11.4 Curis, Inc.
11.4.1 Curis, Inc. Corporation Information
11.4.2 Curis, Inc. Overview
11.4.3 Curis, Inc. Histone Deacetylase 1 Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.4.4 Curis, Inc. Histone Deacetylase 1 Products and Services
11.4.5 Curis, Inc. Histone Deacetylase 1 SWOT Analysis
11.4.6 Curis, Inc. Recent Developments
11.5 GlaxoSmithKline Plc
11.5.1 GlaxoSmithKline Plc Corporation Information
11.5.2 GlaxoSmithKline Plc Overview
11.5.3 GlaxoSmithKline Plc Histone Deacetylase 1 Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.5.4 GlaxoSmithKline Plc Histone Deacetylase 1 Products and Services
11.5.5 GlaxoSmithKline Plc Histone Deacetylase 1 SWOT Analysis
11.5.6 GlaxoSmithKline Plc Recent Developments
11.6 HitGen LTD
11.6.1 HitGen LTD Corporation Information
11.6.2 HitGen LTD Overview
11.6.3 HitGen LTD Histone Deacetylase 1 Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.6.4 HitGen LTD Histone Deacetylase 1 Products and Services
11.6.5 HitGen LTD Histone Deacetylase 1 SWOT Analysis
11.6.6 HitGen LTD Recent Developments
11.7 IRBM Science Park SpA
11.7.1 IRBM Science Park SpA Corporation Information
11.7.2 IRBM Science Park SpA Overview
11.7.3 IRBM Science Park SpA Histone Deacetylase 1 Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.7.4 IRBM Science Park SpA Histone Deacetylase 1 Products and Services
11.7.5 IRBM Science Park SpA Histone Deacetylase 1 SWOT Analysis
11.7.6 IRBM Science Park SpA Recent Developments
11.8 Italfarmaco S.p.A.
11.8.1 Italfarmaco S.p.A. Corporation Information
11.8.2 Italfarmaco S.p.A. Overview
11.8.3 Italfarmaco S.p.A. Histone Deacetylase 1 Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.8.4 Italfarmaco S.p.A. Histone Deacetylase 1 Products and Services
11.8.5 Italfarmaco S.p.A. Histone Deacetylase 1 SWOT Analysis
11.8.6 Italfarmaco S.p.A. Recent Developments
11.9 MEI Pharma, Inc.
11.9.1 MEI Pharma, Inc. Corporation Information
11.9.2 MEI Pharma, Inc. Overview
11.9.3 MEI Pharma, Inc. Histone Deacetylase 1 Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.9.4 MEI Pharma, Inc. Histone Deacetylase 1 Products and Services
11.9.5 MEI Pharma, Inc. Histone Deacetylase 1 SWOT Analysis
11.9.6 MEI Pharma, Inc. Recent Developments
11.10 Merck & Co., Inc.
11.10.1 Merck & Co., Inc. Corporation Information
11.10.2 Merck & Co., Inc. Overview
11.10.3 Merck & Co., Inc. Histone Deacetylase 1 Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.10.4 Merck & Co., Inc. Histone Deacetylase 1 Products and Services
11.10.5 Merck & Co., Inc. Histone Deacetylase 1 SWOT Analysis
11.10.6 Merck & Co., Inc. Recent Developments
11.11 Mirati Therapeutics Inc.
11.11.1 Mirati Therapeutics Inc. Corporation Information
11.11.2 Mirati Therapeutics Inc. Overview
11.11.3 Mirati Therapeutics Inc. Histone Deacetylase 1 Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.11.4 Mirati Therapeutics Inc. Histone Deacetylase 1 Products and Services
11.11.5 Mirati Therapeutics Inc. Recent Developments
11.12 Oncolys BioPharma Inc.
11.12.1 Oncolys BioPharma Inc. Corporation Information
11.12.2 Oncolys BioPharma Inc. Overview
11.12.3 Oncolys BioPharma Inc. Histone Deacetylase 1 Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.12.4 Oncolys BioPharma Inc. Histone Deacetylase 1 Products and Services
11.12.5 Oncolys BioPharma Inc. Recent Developments
11.13 Sigma-Tau S.p.A.
11.13.1 Sigma-Tau S.p.A. Corporation Information
11.13.2 Sigma-Tau S.p.A. Overview
11.13.3 Sigma-Tau S.p.A. Histone Deacetylase 1 Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.13.4 Sigma-Tau S.p.A. Histone Deacetylase 1 Products and Services
11.13.5 Sigma-Tau S.p.A. Recent Developments
11.14 Syndax Pharmaceuticals, Inc.
11.14.1 Syndax Pharmaceuticals, Inc. Corporation Information
11.14.2 Syndax Pharmaceuticals, Inc. Overview
11.14.3 Syndax Pharmaceuticals, Inc. Histone Deacetylase 1 Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.14.4 Syndax Pharmaceuticals, Inc. Histone Deacetylase 1 Products and Services
11.14.5 Syndax Pharmaceuticals, Inc. Recent Developments
11.15 TetraLogic Pharmaceuticals
11.15.1 TetraLogic Pharmaceuticals Corporation Information
11.15.2 TetraLogic Pharmaceuticals Overview
11.15.3 TetraLogic Pharmaceuticals Histone Deacetylase 1 Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.15.4 TetraLogic Pharmaceuticals Histone Deacetylase 1 Products and Services
11.15.5 TetraLogic Pharmaceuticals Recent Developments
12 Value Chain and Sales Channels Analysis
12.1 Histone Deacetylase 1 Value Chain Analysis
12.2 Histone Deacetylase 1 Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Histone Deacetylase 1 Production Mode & Process
12.4 Histone Deacetylase 1 Sales and Marketing
12.4.1 Histone Deacetylase 1 Sales Channels
12.4.2 Histone Deacetylase 1 Distributors
12.5 Histone Deacetylase 1 Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
